Israeli medtech startup QuantalX Neuroscience has partnered with Sheba Medical Center, the largest hospital in both Israel and the entire Middle East, on maintaining brain health as we age.
QuantalX, which developed an early detection device for brain disorders, will work with the Sheba Longevity Center in what the company says is “a pivotal moment in advancing brain health across the lifespan.”
The partnership will see QuantalX’s technology used in early detection of brain disorders and to create personalized treatment plans in order to enhance the quality of life for people in their later years.
“Partnering with Sheba Longevity Center allows us to combine our cutting-edge Delphi-MD technology with world-class expertise to revolutionize brain healthcare,” said QuantalX Neuroscience CEO and co-founder Iftach Dolev.
“The collaboration between the Sheba Longevity Center and QuantalX Neuroscience marks a significant milestone in advancing brain health diagnostics worldwide,” said Sheba Longevity Center Director Prof. Tzipi Strauss.
“By combining our expertise and resources with QuantalX’s state-of-the-art technologies, we are leading a transformative shift in healthcare. This partnership reinforces our dedication to innovative solutions and underscores our commitment to improving health outcomes on a global scale,” she said.
Facebook comments